These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 19041437

  • 1. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
    Ng YW, Liang S, Singh K.
    Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH, Sayed GH, Hussien MM, Shaaban MM.
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 5. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK, Affandi B, Korver T.
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [Abstract] [Full Text] [Related]

  • 6. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO, Endrikat J, Düsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J.
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [Abstract] [Full Text] [Related]

  • 7. Study of the effects of the implantable contraceptive Norplant on lipid and lipoprotein metabolism. UN Development Programme/UN Population Fund/WHO/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-Acting Systemic Agents for Fertility Regulation.
    Contraception; 1999 Jan; 59(1):31-45. PubMed ID: 10342084
    [Abstract] [Full Text] [Related]

  • 8. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
    Rönnerdag M, Odlind V.
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
    [Abstract] [Full Text] [Related]

  • 9. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
    Suvanto-Luukkonen E, Sundström H, Penttinen J, Kauppila A.
    Arch Gynecol Obstet; 1998 Sep; 261(4):201-8. PubMed ID: 9789651
    [Abstract] [Full Text] [Related]

  • 10. [Effects of levonorgestrel-releasing intrauterine system on serum lipids and hepatic function].
    He SM.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1321-2, 1324. PubMed ID: 16234121
    [Abstract] [Full Text] [Related]

  • 11. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P, Lähteenmäki P, Rutanen EM.
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [Abstract] [Full Text] [Related]

  • 12. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
    Ferreira RA, Vieira CS, Rosa-E-Silva JC, Rosa-e-Silva AC, Nogueira AA, Ferriani RA.
    Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
    [Abstract] [Full Text] [Related]

  • 13. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
    Singh K, Ratnam SS.
    Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
    [Abstract] [Full Text] [Related]

  • 14. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P, Bardin CW, Elomaa K, Haukkamaa M, Kivijärvi A, Kuukankorpi A, Venhola M, Tuominen J.
    Acta Obstet Gynecol Scand Suppl; 1997 Aug; 164():69-74. PubMed ID: 9225643
    [Abstract] [Full Text] [Related]

  • 15. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N, Bahamondes L, Bahamondes MV, de Oliveira Santos A, Monteiro I.
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL, Menard J, Rad M, Burggraaf J, de Kam ML, Tokay BA, Sivin I, Kluft C.
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D, Janssens D, Andrade A.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [Abstract] [Full Text] [Related]

  • 19. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
    Bahamondes MV, Monteiro I, Castro S, Espejo-Arce X, Bahamondes L.
    Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.